tiprankstipranks
Advertisement
Advertisement

BOLD Stock Latest News

Boundless Bio reports Q4 EPS (58c), consensus (52c)
The FlyBoundless Bio reports Q4 EPS (58c), consensus (52c)
18d ago
BOLD
Boundless Bio sees cash runway into 2H28
PremiumThe Fly
Boundless Bio sees cash runway into 2H28
18d ago
BOLD
Boundless Bio Advances New Breast Cancer Drug BBI-940 Into First-in-Human Trial
PremiumCompany Announcements
Boundless Bio Advances New Breast Cancer Drug BBI-940 Into First-in-Human Trial
1M ago
BOLD
Boundless Bio announces FDA accepted IND application of BBI-940
PremiumThe Fly
Boundless Bio announces FDA accepted IND application of BBI-940
2M ago
BOLD
Boundless ceases enrollment of Phase 1/2 Potentiate trial of BBI-355, BBI-825
PremiumThe Fly
Boundless ceases enrollment of Phase 1/2 Potentiate trial of BBI-355, BBI-825
2M ago
BOLD
Boundless Bio Terminates Early-Stage BBI-825 Cancer Trial: What Investors Should Know
PremiumCompany AnnouncementsBoundless Bio Terminates Early-Stage BBI-825 Cancer Trial: What Investors Should Know
2M ago
BOLD
Boundless Bio Inc. Reports Q3 2025 Financial Results
Premium
Company Announcements
Boundless Bio Inc. Reports Q3 2025 Financial Results
5M ago
BOLD
Boundless Bio reports Q3 EPS (62c), consensus (58c)
Premium
The Fly
Boundless Bio reports Q3 EPS (62c), consensus (58c)
5M ago
BOLD
Boundless Bio sees cash runway into 1H28
PremiumThe Fly
Boundless Bio sees cash runway into 1H28
5M ago
BOLD
Boundless Bio’s Innovative Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
Boundless Bio’s Innovative Cancer Study: A Potential Game-Changer?
5M ago
BOLD
Innovative Cancer Treatment Approach and Promising Outlook Drive Buy Rating for Boundless Bio Inc.
PremiumRatings
Innovative Cancer Treatment Approach and Promising Outlook Drive Buy Rating for Boundless Bio Inc.
5M ago
BOLD
PremiumRatings
Hold Rating on Boundless Bio Inc.: Awaiting Clinical Validation of Innovative Therapies
8M ago
BOLD
Boundless Bio price target lowered to $4 from $5 at H.C. Wainwright
PremiumThe FlyBoundless Bio price target lowered to $4 from $5 at H.C. Wainwright
8M ago
BOLD
Premium
Company Announcements
Boundless Bio Reports Q2 2025 Financial Results
8M ago
BOLD
Boundless Bio reports Q2 EPS (70c), consensus (65c)
Premium
The Fly
Boundless Bio reports Q2 EPS (70c), consensus (65c)
8M ago
BOLD
Boundless Bio initiated with Early-Stage Biotech at Goldman Sachs
PremiumThe Fly
Boundless Bio initiated with Early-Stage Biotech at Goldman Sachs
8M ago
BOLD
PremiumCompany Announcements
Boundless Bio Elects Directors and Ratifies Auditor
9M ago
8K
BOLD
Boundless Bio initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Boundless Bio initiated with a Buy at H.C. Wainwright
10M ago
BOLD
PremiumCompany Announcements
Boundless Bio Inc. Reports Q1 2025 Financial Results
10M ago
BOLD
PremiumRatingsHold Rating Issued for Boundless Bio Inc. Amid Strategic Setbacks and Delayed Program Validations
10M ago
BOLD
Boundless Bio downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Boundless Bio downgraded to Market Perform from Outperform at Leerink
10M ago
BOLD
Premium
Company Announcements
Boundless Bio Announces Major Workforce Reduction Strategy
10M ago
8K
BOLD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >